A Phase 2b, Double-Blind, Randomized Extension Study to Evaluate the Long-Term Safety and Efficacy of PTC518 in Participants With Huntington’s Disease

Lie, Yenni (Primary Chief Investigator (PCI))

Medicine Monash Health

Project: Research

Project Description

HREC Reference Number: 2023/ETH00958
SSA Code: SSA/102718/MonH-2023-398046(v1)
Monash Health Local Reference: RES-23-0000-733X

Status	Not started

Clinical Trial Phase

Phase II